Tirzepatide, 20 mg, with two solvent ampoules. Tirzepatide is a dual agonist stimulating the GLP-1 and GIP receptors at once, and in registered form a prescription medicine.

Tirzepatide (Mounjaro) 20 mg by Bio-Peptide
200 EUR800,00 złAdd to cartIn stock
Ships within 24 h
What is in this box
One vial with 20 mg of lyophilised tirzepatide and two 1 ml ampoules of solvent. The second ampoule is what sets this version apart. The Genheal box has one, so it gives a single concentration; here you choose. One ampoule makes 20 mg per millilitre, both together make 10 mg per millilitre, and you do not need to buy bacteriostatic water separately.
The lower concentration takes up twice the room in the syringe and is easier to measure. The higher one keeps the volume small. The conversion of an amount into insulin syringe units is worked through in the guide on syringe units, and the rules that change once the powder is dissolved are in storage.
Bio-Peptide as the manufacturer
Bio-Peptide has the widest catalogue of the three brands we stock: it is the only one supplying glutathione, NAD+, GHK-Cu, MOTS-C, SLU-PP-332, semaglutide and Epithalon, so an order from this manufacturer can usually be filled from one supplier. Every vial carries a code under the hologram and a batch certificate, and how to check both is described on the verification page.
What the evidence says
SURMOUNT-5 is the head-to-head trial in obesity without diabetes. In 751 people with obesity and without diabetes, tirzepatide reduced body weight by 20.2 percent over 72 weeks against 13.7 percent for semaglutide, and waist circumference fell by 18.4 cm against 13.0 cm. The full account, with the sources and the limits, is on the Tirzepatide page, and the background in the guide on why tirzepatide acts on two receptors.
We publish no dosing schedules. Sold as research material, not as a medicine, and not the registered product Mounjaro.
Concentration in this vial
| Solvent added | Concentration | Per unit on a U-100 syringe |
|---|---|---|
| 1 ml (one ampoule) | 20 mg/ml | 200 mcg |
| 2 ml (both ampoules) | 10 mg/ml | 100 mcg |
| 5 ml of bacteriostatic water | 4 mg/ml | 40 mcg |
The table is arithmetic and nothing else: it converts the 20 mg in this vial into the concentration you get for a chosen volume of solvent. It is not a dosing recommendation, and we publish none.
This box next to the other Tirzepatide versions
Tirzepatide is sold here in three versions. Genheal, 20 mg holds the same amount of powder with one solvent ampoule. Nouveaux Ltd., 40 mg Quick Pen is a ready solution in a pen, with nothing to dissolve and nothing to convert, twice the amount and a lower price per milligram. The molecule is the same in all three.
Also from Bio-Peptide in this group
Within Weight loss peptides, Bio-Peptide also supplies Retatrutide 20 mg, MOTS-c 10 mg, Semaglutide 3 mg and SLU-PP-332 5 mg.
How much of the lost weight is fat
Tirzepatide is the active substance of the drug Mounjaro. The numbers below come from clinical studies of that drug, run under medical supervision. The research material in this vial is not the drug Mounjaro and has neither its label nor its quality control.
A common question with weight-loss treatment is how much of the lost weight is muscle. In the SURMOUNT-1 trial, body composition was measured by DXA in 160 participants, at the start and after 72 weeks.
| SURMOUNT-1, after 72 weeks | Tirzepatide | Placebo |
|---|---|---|
| Fall in body weight | 21.3 percent | 5.3 percent |
| Fall in fat tissue | 33.9 percent | 8.2 percent |
| Fall in lean mass | 10.9 percent | 2.6 percent |
| Share of fat in the weight lost | about 75 percent | about 75 percent |
So tirzepatide did not change the proportions of what is lost, it only increased the loss itself. People over 65 did not lose proportionally more muscle. In a 2026 meta-analysis of 20 studies, lean mass made up 25.4 percent of the weight lost with tirzepatide and 35.2 percent with semaglutide. This is a comparison across different studies, not a head-to-head one.
Strength training protected muscle best
In the same meta-analysis, diet and exercise with strength training kept the share of lean mass in the weight lost down to 17.5 percent. That is clearly less than with any drug. Alongside training, the authors name an adequate protein intake. MRI in people with diabetes in the SURPASS-3 trial also showed that tirzepatide reduced fat inside the thigh muscles more than the weight loss alone predicted. All the results are gathered in the guide Tirzepatide and muscle.
Sources: Look et al., Diabetes, Obesity and Metabolism 2025, Eisa and Barood, Diabetes, Obesity and Metabolism 2026, Sattar et al., The Lancet Diabetes and Endocrinology 2025.
Questions
Why are there two ampoules in the box?
They give you a choice of concentration. One ampoule makes 20 mg per millilitre, both together 10 mg per millilitre.
How is this different from the Genheal vial?
By the number of solvent ampoules and the manufacturer. Both vials hold 20 mg of the same molecule.
Is this Mounjaro?
No. Mounjaro is a registered prescription medicine. This vial contains research material with the same active substance.
Verification and delivery
Every vial carries a code under the hologram and comes from a batch with a certificate of analysis; how to check both is described in check your product. We ship within Poland and abroad. Outside Poland shipping costs 30 EUR paid in advance or 80 EUR cash on delivery, the same for every country: shipping and payments.
